B23D19/065

Lattice loss reduction
10758495 · 2020-09-01 · ·

Methods for producing systems for the transdermal or permucosal administration of active substances and particularly transdermal therapeutic systems (TTS), wherein the active substance depots thereof have a shape that deviates from a rectangular design.